Shoucheng Boosts Bet on High-End Ophthalmic Tech With Fresh TowardPi Investment

Shoucheng Holdings Ltd. ( (HK:0697) ) has issued an announcement.

Shoucheng Holdings Limited, via a fund managed by its wholly owned subsidiary under Shoucheng Capital, has made an additional investment in TowardPi (Beijing) Medical Technology Group, an innovative producer of high-end ophthalmic medical equipment. TowardPi specializes in ophthalmic imaging diagnostic and therapeutic devices, integrating optical imaging, artificial intelligence and precision manufacturing to provide intelligent, minimally invasive clinical solutions worldwide.

The new capital injection follows an earlier investment in March 2025 and is intended to bolster TowardPi’s working capital, accelerate product research, development and iteration, and support its global commercial expansion, particularly in overseas markets. Shoucheng signaled that it will continue to deepen its布局 in the robotics industry, promoting the integrated development of medical robotics and related supply chains, which may strengthen its positioning in high-end medical technology and potentially enhance value for stakeholders over the longer term.

The most recent analyst rating on (HK:0697) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Shoucheng Holdings Ltd. stock, see the HK:0697 Stock Forecast page.

More about Shoucheng Holdings Ltd.

Shoucheng Holdings Limited operates through its investment arm Shoucheng Capital to back innovative technology and robotics-related businesses, with a particular focus on high-end medical and medical robotics sectors. The group seeks to build industrial ecosystems by partnering with leading niche players and supporting upstream and downstream integration through capital and strategic cooperation.

Average Trading Volume: 64,255,113

Technical Sentiment Signal: Buy

Current Market Cap: HK$14.87B

For a thorough assessment of 0697 stock, go to TipRanks’ Stock Analysis page.